{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:57:15Z","timestamp":1788433035590,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41401-025-01680-x","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T04:02:06Z","timestamp":1767240126000},"page":"964-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A FAPI-based small-molecule drug conjugate alleviates rheumatoid arthritis by targeting pathogenic FAP\u03b1-expressing fibroblasts"],"prefix":"10.1038","volume":"47","author":[{"given":"Hong-yan","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-qiong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao-di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-jun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrullah","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-xiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,1]]},"reference":[{"key":"1680_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","volume":"41","author":"K Almutairi","year":"2021","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021;41:863\u201377.","journal-title":"Rheumatol Int"},{"key":"1680_CR2","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18:591\u2013602.","journal-title":"Nat Rev Rheumatol"},{"key":"1680_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrrheum.2017.95","volume":"13","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Bijlsma JWJ, Cutolo M, McInnes IB. Managing rheumatic and musculoskeletal diseases - past, present and future. Nat Rev Rheumatol. 2017;13:443\u20138.","journal-title":"Nat Rev Rheumatol"},{"key":"1680_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat Rev Rheumatol. 2022;18:415\u201329.","journal-title":"Nat Rev Rheumatol"},{"key":"1680_CR5","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1136\/annrheumdis-2021-222021","volume":"81","author":"T Nemeth","year":"2022","unstructured":"Nemeth T, Nagy G, Pap T. Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?. Ann Rheum Dis. 2022;81:1055\u201364.","journal-title":"Ann Rheum Dis"},{"key":"1680_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13075-024-03343-4","volume":"26","author":"H Qian","year":"2024","unstructured":"Qian H, Deng C, Chen S, Zhang X, He Y, Lan J, et al. Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis. Arthr Res Ther. 2024;26:103.","journal-title":"Arthr Res Ther"},{"key":"1680_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, et al. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430\u20133.","journal-title":"Nature"},{"key":"1680_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp9229","volume":"15","author":"I Melero","year":"2023","unstructured":"Melero I, Tanos T, Bustamante M, Sanmamed MF, Calvo E, Moreno I, et al. A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors. Sci Transl Med. 2023;15:eabp9229.","journal-title":"Sci Transl Med"},{"key":"1680_CR9","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s13346-023-01308-9","volume":"13","author":"S Shahvali","year":"2023","unstructured":"Shahvali S, Rahiman N, Jaafari MR, Arabi L. Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy. Drug Deliv Transl Res. 2023;13:2041\u201356.","journal-title":"Drug Deliv Transl Res"},{"key":"1680_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1135384","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wang J, Lan T, Zhang L, Yan Z, Zhang N, et al. Role and mechanism of fibroblast-activated protein-alpha expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis. Front Immunol. 2023;14:1135384.","journal-title":"Front Immunol"},{"key":"1680_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft AP, Campos J, Jansen K, Turner JD, Marshall J, Attar M, et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature. 2019;570:246\u201351.","journal-title":"Nature"},{"key":"1680_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100702","volume":"21","author":"W Qi","year":"2023","unstructured":"Qi W, Jin L, Wu C, Liao H, Zhang M, Zhu Z, et al. Treatment with FAP-targeted zinc ferrite nanoparticles for rheumatoid arthritis by inducing endoplasmic reticulum stress and mitochondrial damage. Mater Today Bio. 2023;21:100702.","journal-title":"Mater Today Bio"},{"key":"1680_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2478\/rir-2023-0013","volume":"4","author":"X Zhang","year":"2023","unstructured":"Zhang X, Jozic A, Song P, Xu Q, Shi X, Wang H, et al. mRNA vaccine against fibroblast activation protein ameliorates murine models of inflammatory arthritis. Rheumatol Immunol Res. 2023;4:90\u20137.","journal-title":"Rheumatol Immunol Res"},{"key":"1680_CR14","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222052","volume":"307","author":"Y Luo","year":"2023","unstructured":"Luo Y, Pan Q, Zhou Z, Li M, Wei Y, Jiang X, et al. 68Ga-FAPI PET\/CT for rheumatoid arthritis: a prospective study. Radiology. 2023;307:e222052.","journal-title":"Radiology"},{"key":"1680_CR15","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1007\/s00259-022-05836-3","volume":"49","author":"L Ge","year":"2022","unstructured":"Ge L, Fu Z, Wei Y, Shi D, Geng Y, Fan H, et al. Preclinical evaluation and pilot clinical study of [18F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis. Eur J Nucl Med Mol Imaging. 2022;49:4025\u201336.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1680_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-01064-4","volume":"14","author":"Q Pan","year":"2024","unstructured":"Pan Q, Yang H, Zhou Z, Li M, Jiang X, Li F, et al. [68Ga]Ga-FAPI-04 PET\/CT may be a predictor for early treatment response in rheumatoid arthritis. EJNMMI Res. 2024;14:2.","journal-title":"EJNMMI Res"},{"key":"1680_CR17","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1158\/1078-0432.CCR-22-1788","volume":"28","author":"A Zana","year":"2022","unstructured":"Zana A, Galbiati A, Gilardoni E, Bocci M, Millul J, Sturm T, et al. Fibroblast activation protein triggers release of drug payload from non-internalizing small molecule drug conjugates in solid tumors. Clin Cancer Res. 2022;28:5440\u201354.","journal-title":"Clin Cancer Res"},{"key":"1680_CR18","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxf). 2012;51:vi5\u20139.","journal-title":"Rheumatology (Oxf)"},{"key":"1680_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jconrel.2024.02.014","volume":"367","author":"M Bocci","year":"2024","unstructured":"Bocci M, Zana A, Principi L, Lucaroni L, Prati L, Gilardoni E, et al. In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment. J Control Release. 2024;367:779\u201390.","journal-title":"J Control Release"},{"key":"1680_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2:1269\u201375.","journal-title":"Nat Protoc"},{"key":"1680_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204998","volume":"10","author":"Y Liu","year":"2023","unstructured":"Liu Y, Rao P, Qian H, Shi Y, Chen S, Lan J, et al. Regulatory fibroblast-like synoviocytes cell membrane coated nanoparticles: a novel targeted therapy for rheumatoid arthritis. Adv Sci (Weinh). 2023;10:e2204998.","journal-title":"Adv Sci (Weinh)"},{"key":"1680_CR22","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389:2338\u201348.","journal-title":"Lancet"},{"key":"1680_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113074","volume":"150","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Hua Z, Luo X, Li Y, Yu L, Li M, et al. Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother. 2022;150:113074.","journal-title":"Biomed Pharmacother"},{"key":"1680_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152909","volume":"461","author":"R Katturajan","year":"2021","unstructured":"Katturajan R, Rasool SV, Evan Prince M. S. Molecular toxicity of methotrexate in rheumatoid arthritis treatment: A novel perspective and therapeutic implications. Toxicology. 2021;461:152909.","journal-title":"Toxicology"},{"key":"1680_CR25","doi-asserted-by":"publisher","first-page":"4S","DOI":"10.2967\/jnumed.123.266983","volume":"65","author":"L Zhao","year":"2024","unstructured":"Zhao L, Kang F, Pang Y, Fang J, Sun L, Wu H, et al. Fibroblast activation protein inhibitor tracers and their preclinical, translational, and clinical status in China. J Nucl Med. 2024;65:4S\u201311S.","journal-title":"J Nucl Med"},{"key":"1680_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13075-024-03406-6","volume":"26","author":"B Bergstrom","year":"2024","unstructured":"Bergstrom B, Sellden T, Bollmann M, Svensson MND, Ekwall AH. Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling. Arthritis Res Ther. 2024;26:178.","journal-title":"Arthritis Res Ther"},{"key":"1680_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41584-024-01169-7","volume":"20","author":"V Konzett","year":"2024","unstructured":"Konzett V, Aletaha D. Management strategies in rheumatoid arthritis. Nat Rev Rheumatol. 2024;20:760\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"1680_CR28","doi-asserted-by":"publisher","first-page":"e070856","DOI":"10.1136\/bmj-2022-070856","volume":"384","author":"P Brown","year":"2024","unstructured":"Brown P, Pratt AG, Hyrich KL. Therapeutic advances in rheumatoid arthritis. BMJ. 2024;384:e070856.","journal-title":"BMJ"},{"key":"1680_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","volume":"21","author":"S Davidson","year":"2021","unstructured":"Davidson S, Coles M, Thomas T, Kollias G, Ludewig B, Turley S, et al. Fibroblasts as immune regulators in infection, inflammation and cancer. Nat Rev Immunol. 2021;21:704\u201317.","journal-title":"Nat Rev Immunol"},{"key":"1680_CR30","doi-asserted-by":"publisher","first-page":"19441","DOI":"10.1074\/jbc.C500092200","volume":"280","author":"K Aertgeerts","year":"2005","unstructured":"Aertgeerts K, Levin I, Shi L, Snell GP, Jennings A, Prasad GS, et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J Biol Chem. 2005;280:19441\u20134.","journal-title":"J Biol Chem"},{"key":"1680_CR31","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/rheumatology\/keaa295","volume":"59","author":"DN Dorst","year":"2020","unstructured":"Dorst DN, Rijpkema M, Boss M, Walgreen B, Helsen MMA, Bos DL, et al. Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis. Rheumatology (Oxf). 2020;59:3952\u201360.","journal-title":"Rheumatology (Oxf)"},{"key":"1680_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-187","volume":"11","author":"PC Schuberth","year":"2013","unstructured":"Schuberth PC, Hagedorn C, Jensen SM, Gulati P, van den Broek M, Mischo A, et al. Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. J Transl Med. 2013;11:187.","journal-title":"J Transl Med"},{"key":"1680_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40850-5","volume":"14","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Todd L, Huang L, Noguera-Ortega E, Lu Z, Huang L, et al. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat Commun. 2023;14:5110.","journal-title":"Nat Commun"},{"key":"1680_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik JG, Tombacz I, Yadegari A, Mendez Fernandez PO, Shewale SV, Li L, et al. CAR T cells produced in vivo to treat cardiac injury. Science. 2022;375:91\u20136.","journal-title":"Science"},{"key":"1680_CR35","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S2665-9913(23)00069-3","volume":"5","author":"A Rubbert-Roth","year":"2023","unstructured":"Rubbert-Roth A. Methotrexate in rheumatoid arthritis-another brick in the wall. Lancet Rheumatol. 2023;5:e173\u2013e5.","journal-title":"Lancet Rheumatol"},{"key":"1680_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020;16:145\u201354.","journal-title":"Nat Rev Rheumatol"},{"key":"1680_CR37","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis. 2009;68:1100\u20134.","journal-title":"Ann Rheum Dis"},{"key":"1680_CR38","first-page":"S95","volume":"28","author":"K Albrecht","year":"2010","unstructured":"Albrecht K, Muller-Ladner U. Side effects and management of side effects of methotrexate in rheumatoid arthritis. Clin Exp Rheumatol. 2010;28:S95\u2013101.","journal-title":"Clin Exp Rheumatol"},{"key":"1680_CR39","doi-asserted-by":"publisher","first-page":"16118","DOI":"10.1021\/acsnano.2c04491","volume":"16","author":"M Jeong","year":"2022","unstructured":"Jeong M, Jung Y, Yoon J, Kang J, Lee SH, Back W, et al. Porous Silicon-based nanomedicine for simultaneous management of joint inflammation and bone erosion in rheumatoid arthritis. ACS Nano. 2022;16:16118\u201332.","journal-title":"ACS Nano"},{"key":"1680_CR40","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1021\/acs.biomac.4c00556","volume":"25","author":"Y Liu","year":"2024","unstructured":"Liu Y, Luo H, Liu B, Zhou T, Zhang Z, Liu Z. Biomimetic NO scavenging hyaluronic acid nanoparticles enable targeted delivery of MTX and integrated management of rheumatoid arthritis. Biomacromolecules. 2024;25:4557\u201368.","journal-title":"Biomacromolecules"},{"key":"1680_CR41","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.7150\/thno.102627","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Su W, He L, Wu D, Liu N, Zhu J, et al. Dual targeting heterodimer PET tracer [18F]AlF\u2011FAPI\u2011RGD in patients with rheumatoid arthritis: a pilot exploratory study. Theranostics. 2024;14:7042\u201353.","journal-title":"Theranostics"},{"key":"1680_CR42","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang Q, Zhang Y, Wang J, Wu Y, Yang G, et al. 99mTc-labeled FAPI SPECT imaging in idiopathic pulmonary fibrosis: preliminary results. Pharmaceuticals (Basel). 2023;16:1434.","DOI":"10.3390\/ph16101434"},{"key":"1680_CR43","doi-asserted-by":"publisher","DOI":"10.34133\/research.0282","volume":"6","author":"W Huang","year":"2023","unstructured":"Huang W, Pang Y, Liu Q, Liang C, An S, Wu Q, et al. Development and characterization of novel FAP-targeted theranostic pairs: a bench-to-bedside study. Research. 2023;6:0282.","journal-title":"Research"},{"key":"1680_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41413-022-00243-8","volume":"11","author":"A Fan","year":"2023","unstructured":"Fan A, Wu G, Wang J, Lu L, Wang J, Wei H, et al. Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression. Bone Res. 2023;11:3.","journal-title":"Bone Res"},{"key":"1680_CR45","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jcmgh.2022.12.005","volume":"15","author":"AT Yang","year":"2023","unstructured":"Yang AT, Kim YO, Yan XZ, Abe H, Aslam M, Park KS, et al. Fibroblast activation protein activates macrophages and promotes parenchymal liver inflammation and fibrosis. Cell Mol Gastroenterol Hepatol. 2023;15:841\u201367.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1680_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","volume":"66","author":"R Conway","year":"2014","unstructured":"Conway R, Low C, Coughlan RJ, O\u2019Donnell MJ, Carey JJ. Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheumatol. 2014;66:803\u201312.","journal-title":"Arthritis Rheumatol"},{"key":"1680_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41584-022-00883-4","volume":"19","author":"V Di Martino","year":"2023","unstructured":"Di Martino V, Verhoeven DW, Verhoeven F, Aubin F, Avouac J, Vuitton L, et al. Busting the myth of methotrexate chronic hepatotoxicity. Nat Rev Rheumatol. 2023;19:96\u2013110.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01680-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01680-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01680-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:02:08Z","timestamp":1774479728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01680-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1680"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01680-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}